STI Clinical Update Webinar – HCV in 2026: A Clinical Update and Review

January 20, 2026
10:30 am -12:00 pm (PST)
1.5 CME units at no cost
Registration closes on January 16, 2026 at 3:00PM (PST)

Presenters

Norah Terrault, MD, MPH, FAASLD
Professor of Medicine
Chief, Division of Gastrointestinal and Liver Diseases
Neil Kaplowitz Chair in Liver Diseases
Keck School of Medicine of USC
University of Southern California

Kurtis Mohr, MD, AAHIVM
Public Health Medical Officer, Office of STIs and HCV
California Department of Public Health

Course Description

Co-sponsored by the California Department of Public Health and California Prevention Training Center at the University of California San Francisco, this STI Clinical Update webinar will provide a comprehensive review of hepatitis C (HCV) in 2026, focusing on clinical cases and test-to-treat models of care.

Learning Objectives

Understand and apply the test-to-treat model for hepatitis C
Participants will learn how to initiate direct-acting antiviral (DAA) therapy at the point of diagnosis, including in community settings, using Dr. Terrault, AASLD or CDPH, or other simplified treatment pathways. Literature supporting the effectiveness and feasibility of test-to-treat will be reviewed.
Use case-based scenarios to identify key clinical considerations
Through interactive case studies, providers will explore how to interpret relevant lab values, assess comorbidities, and evaluate potential drug interactions when initiating DAA therapy. Emphasis will be placed on practical decision-making using simplified treatment algorithms.
Implement appropriate monitoring and follow-up during hepatitis C treatment
Attendees will learn recommended baseline and follow-up laboratory testing, including HCV RNA viral load timing, and understand whether there is a need for and the frequency and purpose of clinical follow-up visits throughout the treatment course.

To request an accommodation for this event, please email captc@ucsf.edu at least a week in advance of the event.